Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2021
Signalling transduction of O-GlcNAcylation and PI3K/AKT/mTOR-axis in prostate cancerVivek Makwana, Santosh Rudrawar, Shailendra Anoopkumar-Dukie
International Journal of Toxicology|August 28, 2020
Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 CellsVivek Makwana, A/Prof Shailendra-Anoopkumar Dukie, Santosh Rudrawar
International Journal of Pharmaceutics|September 15, 2015
Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approachVivek Makwana, Rashmi Jain, Komal Patel, et al.
International Journal of Pharmaceutics|December 1, 2020
Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalizationVivek Makwana, Jasmine Karanjia, Thomas Haselhorst, et al.
Biochimica Et Biophysica Acta. General Subjects|April 30, 2019
Essential role of O-GlcNAcylation in stabilization of oncogenic factorsVivek Makwana, Philip Ryan, Bhautikkumar Patel, et al.
Chemmedchem|September 29, 2020
Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase InhibitorsVivek Makwana, Philip Ryan, Alpeshkumar K Malde, et al.
European Journal of Medicinal Chemistry|April 2, 2019
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraYBhautikkumar Patel, Philip Ryan, Vivek Makwana, et al.
ACS Chemical Neuroscience|May 22, 2018
Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's DiseasePhilip Ryan, Bhautikkumar Patel, Vivek Makwana, et al.
Pageof 1